上海林清軒化妝品集團股份有限公司 章 程 （首 次 公 開 發 行H股 後 適 用） | 第一章 | 總 | | | | 1 | | | | | 則 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 第二章 | | | | | 3 | 經營宗旨和範圍 | | | | | | | | | | | | | | 第三章 | 股 | | | | 4 | | | | | 份 | | | | | | | | | | 第一節 | | | | | 4 | | 股份發行 | | | | | | | | | | | | | 第二節 | | | 股份增減和回購 | | 7 | | | | | | | | | | | | | | | 第三節 | | | | | 9 | | 股份轉讓 | | | | | | | | | | | | | 第四章 | | | | | 10 | | 股東和股東會 | | | | | | | ...

智通财经APP讯，林清轩(02657)发布公告，于2026年1月27日，根据悉数行使超额配股权而发行及配发 209.5万股H股。 ...

格隆汇1月27日丨林清轩(02657.HK)发布公告，根据悉数行使超额配股权而于2026年1月27日发行及配发 209.495万股H股。 ...

林清轩(02657)发布公告，于2026年1月27日，根据悉数行使超额配股权而发行及配发209.5万股H股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 上海林清軒化妝品集團股份有限公司 呈交日期： 2026年1月27日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 根據《主板上市規則》第13.25C條 / 《GEM上市規則》第17.27C條，我們在此確認，據我們所知所信，第一章節所述的每項股份發行或庫存股份出售或轉讓已獲發行人董事會正式授權批准，並遵 照所有適用上市規則、法律及其他監管規定進行，並在適用的情況下： (註7) (i) 上市發行人已收取其在是次股份發行或庫存股份出售或轉讓應得的全部款項； (viii) 有關債券、借貸股份、票據或公司債券的信託契約/平邊契據經已製備及簽署，有關詳情已送呈公司註冊處處長存檔（如法律如此規定）。 第一章節註釋： 若股份曾以超過一個每股價格發行/出 ...

Core Viewpoint - The company has successfully captured the high-end anti-wrinkle essence oil market through a differentiated approach using camellia flower ingredients, launching its core product in 2014 and adopting an "oil-based skincare" concept, leading to a projected revenue CAGR of 32% from 2022 to 2024 and a turnaround in net profit [1][2] Product Strategy - The company focuses on high-end positioning with its camellia flower essence oil, which has undergone five iterations since its launch, enhancing its efficacy and gradually increasing its price range, with the essence oil series accounting for 45% of revenue in the first half of 2025 [2][4] - The product line is expected to expand under the "1+4+N" strategy, incorporating creams, toners, sunscreens, and masks, while maintaining a flagship product strategy [4][5] User Demographics - The company initially targeted mature customers through offline channels but has shifted to online channels since 2020, attracting younger consumers aged 25-40, primarily from new first-tier and second-tier cities [3][4] Channel Strategy - In the first half of 2025, offline and online channels generated revenues of 3.64 billion yuan (+51.5%) and 6.88 billion yuan (+137%), respectively, with online sales accounting for 65.4% of total revenue [3][4] - The company plans to expand its offline store network primarily through direct sales, optimizing existing stores to enhance efficiency and customer retention [5][6] Growth Drivers - The company is positioned for significant growth in the essence oil market, with a projected online GMV of approximately 10 billion yuan for the first half of 2025, indicating room for improvement compared to competitors [4][6] - Future growth is expected to come from both internal product development and potential acquisitions, with a focus on enhancing brand presence and expanding product offerings [6][7] Financial Projections - Revenue forecasts for 2025-2027 are 22.1 billion yuan, 31.1 billion yuan, and 42.0 billion yuan, with corresponding net profits of 3.51 billion yuan, 5.70 billion yuan, and 7.71 billion yuan, reflecting strong growth rates [6][7]

Core Viewpoint - Lin Qingxuan (02657) has exercised the overall coordinator's over-allotment option, involving a total of 2.095 million H shares, which is approximately 15% of the total number of shares initially available for subscription under the global offering [1] Group 1 - The over-allotment shares will be issued at a price of HKD 77.77 per H share, excluding various transaction fees [1] - The stabilization period for the global offering will end on January 22, 2026, which is the 30th day after the deadline for submitting applications for the Hong Kong public offering [1] - Further details regarding the stabilization actions taken by the stabilization agent, China International Capital Corporation Limited, or its affiliates, are included in the announcement [1]

Core Viewpoint - The company Lin Qingxuan (02657.HK) announced the full exercise of the over-allotment option involving a total of 2,094,950 H-shares, which represents approximately 15% of the total number of shares initially available for subscription under the global offering [1] Group 1 - The overall coordinator, representing international underwriters, has exercised the over-allotment option on January 22, 2026 [1] - The over-allotted shares will be issued at a price of HKD 77.77 per H-share, excluding various fees [1] - The stabilization period for the global offering, as per Hong Kong legislation, ended on January 22, 2026, which is 30 days after the deadline for public offering applications [1]

香 港 交 易 及 結 算 所 有 限 公 司、香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）及香港中央 結 算 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 本公告不會直接或間接在或向美國（包 括 其 領 土 及 屬 地、美 國 任 何 州 以 及 哥 倫 比 亞 特 區）發 布、刊 發 或 派 發。本 公 告 並 不 亦 無 意 構 成 或 組 成 於 美 國 或 於 任 何 其 他 司 法 權 區 購 買 或 認 購 證 券 的 任 何 要 約 或 招 攬 的 一 部 分。本 公 告 所 述 證 券 並無亦將不會根據1933年美國證券法（經 不 時 修 訂）（「美國證券法」）或美國任何 州 或 其 他 司 法 權 區 的 證 券 法 登 記。證 券 不 得 在 美 國 境 內 提 呈 發 售、出 售、抵 押 或 以 其 他 方 式 ...

Group 1: Lin Qingxuan (02657HK) Overview - Lin Qingxuan is a leading high-end domestic skincare brand in China, established in 2003, focusing on the "oil-based skincare" concept using camellia oil as a core ingredient [2][11][13] - The company's revenue is projected to grow from 690 million yuan in 2022 to 1.21 billion yuan in 2024, with a CAGR of 32.7%, while net profit is expected to turn from a loss of 6 million yuan to a profit of 187 million yuan, representing a 120% year-on-year increase in 2024 [2][11][13] - The brand's market share in the high-end skincare segment is 1.4%, making it the only domestic representative among the top 15 high-end skincare brands in China for 2024 [11][13] Group 2: Market Trends and Opportunities - The skincare market in China has reached a scale of 400 billion yuan, with significant growth potential in per capita spending compared to Western markets [11][13] - The segment of facial essence oils is expected to grow at a CAGR of 42.8% from 2019 to 2024, significantly outpacing the overall industry growth [11][13] - The high-end skincare market is projected to expand to 218.5 billion yuan by 2029, driven by the mainstream adoption of the "oil-based skincare" concept [11][13] Group 3: Product and Channel Strategy - Lin Qingxuan has successfully upgraded its core product, the camellia essence oil, to its fifth generation, achieving cumulative sales of over 45 million bottles and maintaining the top position in the national facial essence oil sales for 11 consecutive years [11][13] - The company is enhancing its product matrix with stable growth in other products like creams and essence waters, while also focusing on R&D breakthroughs to improve product efficacy [11][13] - The brand's omnichannel strategy includes nearly 600 physical stores and a strong online presence, with online sales accounting for 65.4% of total revenue in the first half of 2025 [11][13] Group 4: Financial Projections - The projected net profits for Lin Qingxuan from 2025 to 2027 are 347 million yuan, 577 million yuan, and 820 million yuan, respectively, with year-on-year growth rates of 86%, 66%, and 42% [11][13] - The price-to-earnings (PE) ratios for the same years are expected to be 31, 18, and 13 times, indicating a favorable valuation outlook [11][13] Group 5: Hong Kong Stock Market Analysis - The "January Effect" in the Hong Kong stock market is attributed to the return of overseas investors and the gradual inflow of foreign capital into Chinese assets, which is expected to continue [4][12][14] - The market's liquidity environment has improved compared to the end of the previous year, with a notable increase in trading activity and a decrease in short-selling [14] - Despite the positive trends, the market remains sensitive to fluctuations in overseas risk appetite and domestic economic conditions [14]